Free Trial
NASDAQ:MENS

Jyong Biotech (MENS) Stock Price, News & Analysis

$31.98 +3.05 (+10.54%)
As of 08/6/2025 04:00 PM Eastern

About Jyong Biotech Stock (NASDAQ:MENS)

Key Stats

Today's Range
$27.98
$31.98
50-Day Range
N/A
52-Week Range
$6.01
$31.98
Volume
190,507 shs
Average Volume
82,257 shs
Market Capitalization
$2.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jyong Biotech and its competitors with MarketBeat's FREE daily newsletter.

MENS Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
See More Headlines

MENS Stock Analysis - Frequently Asked Questions

Jyong Biotech's stock was trading at $8.50 at the beginning of 2025. Since then, MENS stock has increased by 276.2% and is now trading at $31.98.

Jyong Biotech (MENS) raised $20 million in an IPO on Tuesday, June 17th 2025. The company issued 2,666,667 shares at $7.50 per share.

Jyong Biotech's quiet period expired on Monday, July 28th. Jyong Biotech had issued 2,666,667 shares in its IPO on June 17th. The total size of the offering was $20,000,003 based on an initial share price of $7.50. During Jyong Biotech's quiet period, insiders and underwriters that worked on the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of MENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MENS
Previous Symbol
NASDAQ:MENS
CIK
1954488
Web
N/A
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
76,030,000
Free Float
N/A
Market Cap
$2.43 billion
Optionable
N/A
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:MENS) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners